Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%

NCT00440011 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT00440011
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00440011 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%
Lead sponsor
Allergan
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2006
Completion date
October 31, 2007
Enrollment
266 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, ocular hypertension